Clip Closes Arteries From Outside

An extravascular closure system developed by Abbott Vascular Devices (Abbot Park, IL, USA) features a nitinol clip designed to achieve a secure closure of the femoral artery access site following diagnostic or interventional vascular procedures. The system has been approved by the U.S. Food and Drug Administration (FDA), following previous approval in many other countries.

The StarClose system consists of the clip applier, clips, and the exchange system. The heart of the system is a circumferential nitinol clip--that provides 360o tissue apposition—
mounted on the applier and delivered through a 5- or 6-French puncture site procedural sheath exchange system used during the intervention. This through-the-sheath (TTS) approach expedites patient management, as extra guide wire insertion and sheath exchange steps are removed from the procedure. Since the same pathway established during the catheterization procedure is used to deliver the clip directly to the puncture site, procedure times are shortened, thereby expediting hemostasis, ambulation, and dischargeability, as well as avoiding potential contamination from contact with the skin.

According to Abbbot, only four clicks of the device are required to achieve a secure extravascular closure. The clip closes the closure site entirely from the outside of the vessel.

The innovative StarClose system provides an original approach to managing vascular access sites, stated Tony Chou, M.D., general manager of the vessel closure technologies section at Abbott Vascular Devices. It incorporates a high degree of confidence in gaining hemostasis, a rapid means of deployment, and it gives physicians a true through-the-sheath approach. StarClose is the result of a focus on clinically beneficial technologies with ground-breaking advances to help the physician and patient to obtain successful procedural outcomes.



Related Links:
Abbott Vascular Devices